THOMAS J DI FILIPPO
Allopathic & Osteopathic Physicians|Family Medicine MUNSTER, IN NPI 1649226002
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine IN Novo Nordisk AS All categories
General Payments — all program years on this page
$4,250.53
- Category: General Payments
- Program years: PY2018–2024
- Record count: 187
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $659.89 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $659.89 | 7 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $216.96 | 3 |
| Madrigal Pharmaceuticals | $124.16 | 1 |
| Acerta Pharma LLC | $119.09 | 1 |
| Phathom Pharmaceuticals, Inc. | $104.43 | 1 |
| Amgen Inc. | $95.25 | 1 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1096603345 | Novo Nordisk Inc | $82.54 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1097115115 | Novo Nordisk Inc | $13.77 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1097771865 | Novo Nordisk Inc | $120.65 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104688810 | AstraZeneca Pharmaceuticals LP | $119.09 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1115576312 | Amgen Inc. | $95.25 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1144164577 | Madrigal Pharmaceuticals | $124.16 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1151055695 | Phathom Pharmaceuticals, Inc. | $104.43 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.